Netherlands · Delayed Price · Currency is EUR Vivoryon Therapeutics Statistics
Total Valuation
AMS:VVY has a market cap or net worth of EUR 48.51 million. The enterprise value is 43.74 million.
| Market Cap | 48.51M |
| Enterprise Value | 43.74M |
Important Dates
The next estimated earnings date is Monday, December 8, 2025.
| Earnings Date | Dec 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMS:VVY has 29.61 million shares outstanding. The number of shares has increased by 3.18% in one year.
| Current Share Class | 29.61M |
| Shares Outstanding | 29.61M |
| Shares Change (YoY) | +3.18% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 6.62% |
| Owned by Institutions (%) | 19.18% |
| Float | 25.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 15.25 |
| P/TBV Ratio | 20.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.50 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.22 |
Financial Position
The company has a current ratio of 4.04, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.04 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.01 |
| Interest Coverage | -264.06 |
Financial Efficiency
Return on equity (ROE) is -145.47% and return on invested capital (ROIC) is -91.89%.
| Return on Equity (ROE) | -145.47% |
| Return on Assets (ROA) | -67.68% |
| Return on Invested Capital (ROIC) | -91.89% |
| Return on Capital Employed (ROCE) | -247.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -891,571 |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -29.09% in the last 52 weeks. The beta is 1.96, so AMS:VVY's price volatility has been higher than the market average.
| Beta (5Y) | 1.96 |
| 52-Week Price Change | -29.09% |
| 50-Day Moving Average | 1.64 |
| 200-Day Moving Average | 1.70 |
| Relative Strength Index (RSI) | 53.35 |
| Average Volume (20 Days) | 70,505 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.68M |
| Pretax Income | -12.48M |
| Net Income | -12.48M |
| EBITDA | -12.59M |
| EBIT | -12.68M |
| Earnings Per Share (EPS) | -0.48 |
Balance Sheet
The company has 4.84 million in cash and 72,000 in debt, giving a net cash position of 4.77 million or 0.16 per share.
| Cash & Cash Equivalents | 4.84M |
| Total Debt | 72,000 |
| Net Cash | 4.77M |
| Net Cash Per Share | 0.16 |
| Equity (Book Value) | 3.18M |
| Book Value Per Share | 0.12 |
| Working Capital | 3.95M |
Cash Flow
In the last 12 months, operating cash flow was -10.37 million and capital expenditures -6,000, giving a free cash flow of -10.38 million.
| Operating Cash Flow | -10.37M |
| Capital Expenditures | -6,000 |
| Free Cash Flow | -10.38M |
| FCF Per Share | -0.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMS:VVY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.18% |
| Shareholder Yield | -3.18% |
| Earnings Yield | -25.73% |
| FCF Yield | -21.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |